Insider Profile · SEC Form 4 Activity · Trailing 90 Days
Gline Matthew
Over the trailing 90 days, Gline Matthew (Director at Roivant Sciences Ltd.) sold $2.7M of stock in ROIV, per 1 SEC Form 4 transaction.
- Role
- Director
- Companies
- ROIV
- Window
- Trailing 90 days · 1 transactions · CIK 1750094
- Net activity
- −$2.7M ($0 bought · $2.7M sold)
By Company (Trailing 90 Days)
| Symbol | Company | Txns | Bought | Sold | Net |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd. | 1 | — | $2.7M | −$2.7M |
Transactions (1)
| Date | Symbol | Type | Shares | Value | Description |
|---|---|---|---|---|---|
| 2026-06-30 | ROIV | Sell | 76.2K | $2.7M | Payment of exercise price or tax liability by delivering securities |
Activity shown covers the trailing 90 days of SEC Form 4 filings. "Buy" and "sell" follow the SEC acquired/disposed codes and include compensation events (grants, option exercises, tax withholding) unless noted. Historical fact, not investment advice.
Follow Gline's next move
Real-time Form 4 alerts, insider track records, and cluster detection — matched to your watchlist.